BD Diagnostics launches ‘Be a Flu Fighter’ initiative
SAN DIEGO BD Diagnostics, a segment of Becton, Dickinson and Co., on Wednesday launched its “Be a Flu Fighter” initiative, a program aimed at increasing awareness and preventing influenza.
BD designed the “Be a Flu Fighter” initiative to enhance the ability of healthcare professionals at schools, hospitals, laboratories and other public/private settings to help slow the predicted, rapid spread of influenza by promoting good hygiene, vaccination and other flu prevention strategies. With straightforward, accessible language and graphics, the complimentary, printer-friendly materials can be easily downloaded from www.bd.com/ds/flufighter. The BD site also provides hospitals and laboratories with informational materials designed to help professionals properly obtain and handle specimens for flu diagnosis.
“As a world leader in health care, BD is pleased to provide these much-needed resources. Our role goes beyond providing quality products, and includes enabling healthcare professionals to effectively spread the word about practices that can lead to better prevention, diagnosis and therapy for infectious diseases, such as influenza,” stated Tobi Karchmer, medical director BD Diagnostics.
Lysol launches no-touch hand soap system
PARSIPPANY, N.J. Lysol has expanded its fight against germs into personal care with the introduction of the no-touch hand soap system.
Lysol’s Healthy Touch no-touch hand soap system starter kits are now available in soothing cucumber splash scent and cleansing green tea & ginger scent at Walmart for a suggested retail price of $9.97 (includes 1-dispenser, 1-8.5 oz. hand soap refill and 4 AA batteries). Hand soap refills (8.5 oz.) are available in three fresh scents, Soothing cucumber splash scent, cleansing green tea & ginger scent and refreshing grapefruit essence scent at Walmart for a suggested retail price of $3.47. Starter kits and hand soap refills will also be available at grocery, drug and mass stores nationwide.
Study finds full use of nicotine-patch therapy may prevent relapse
PHILADELPHIA Future ex-smokers who utilize a nicotine-patch therapy longer may be less likely to relapse, according to a study published in Tuesday’s edition of the Annals of Internal Medicine, a journal of the American College of Physicians.
Over the course of a placebo-controlled trial from September 2004 through February 2008, 568 adult smokers were randomly assigned GlaxoSmithKline’s Nicoderm CQ for the product-recommended eight weeks followed by use of a placebo patch for 16 weeks or use of the Nicoderm CQ patch for the full 24 weeks.
At the conclusion of the study, those participants who had used the Nicoderm patch for a full 24 weeks were 19.2% more likely to have quit smoking altogether.
Extended therapy not only reduced the risk for lapse, but also increased the chances of recovery from lapses, according to the journal report.
There were differences in side effects and adverse events between the two groups.
The study was funded by the National Institutes of Health.